Importance of genotyping of thiopurine S-methyltransferase in children with acute lymphoblastic leukaemia during maintenance therapy

Srpski Arhiv za Celokupno Lekarstvo

Volumn 136, Issue 11-12, 2008, Pages 609-616

  Dokmanović, Lidija ^a   Janić, Dragana ^a   Krstovski, Nada ^a   Zukić, Branka ^b   Tošić, Nataša ^b   Pavlović, Sonja ^b  

^a UNIVERSITY CHILDREN S HOSPITAL   (Serbia)

^b INSTITUTE OF MOLECULAR GENETICS AND GENETIC ENGINEERING   (Serbia)

Author keywords

Acute lymphoblastic leukaemia; Children; Pharmacogenetics; Thiopurine S methyltransferase

Indexed keywords

ANTINEOPLASTIC ANTIMETABOLITE; MERCAPTOPURINE; METHYLTRANSFERASE; THIOPURINE METHYLTRANSFERASE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; CHILD; DRUG CONTRAINDICATION; GENETICS; HUMAN; INFANT; MUTATION; PRESCHOOL CHILD;

6-MERCAPTOPURINE; ADOLESCENT; ANTIMETABOLITES, ANTINEOPLASTIC; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; METHYLTRANSFERASES; MUTATION; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;

EID: 60549089401     PISSN: 03708179     EISSN: None     Source Type: Journal    
DOI: 10.2298/SARH0812609D     Document Type: Article

References (31)

1. Weinshilboum RM, Sladek SL. Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity. Am J Hum Genet 1980; 32:651-662.
2. Varagić V, Milošević M. Farmakologija. 20th ed. Beograd: Elit Medica; 2005.
3. Evans WE, Hon YY, Bomgaars L, et al. Preponderance of thiopurine S-methyltransferase deficiency and heterozygosity among patients intolerant to mercaptopurine or azathioprine. J Clin Oncol 2001; 19(8):2293-2301.
4. Black AJ, McLeod HL, Capell HA, Powrie RH, Matowe LK, Pritchard SC. Thiopurine methyltransferase genotype predicts therapy limiting severe toxicity from azathioprine. Ann Intern Med 1998; 129:716-718.
5. Relling MV, Hancook ML, Boyett JM, Pui C-H, Evans WE. Prognostic importance of 6-mercaptopurine dose intensity in acute lymphoblastic leukemia. Blood 1999; 93:2817-2823.
6. Banerjee S, Bishop WP. Evolution of thiopurine use in pediatric inflammatory bowel disease in an academic center. J Pediatr Gastroenterol Nutr 2006; 43(3):324-330.
7. Song DK, Zhao J, Zhang LR. TPMT genotype and its clinical implication in renal transplant recipients with azathioprine treatment. J Clin Pharm Ther 2006; 31(6):627-635.
8. Dokmanović L, Urosevic J, Janic D, et al. Analysis of thiopurine S-methyltransferase polymorphism in the population of Serbia and Montenegro and mercaptopurine therapy tolerance in childhood acute lymphoblastic leukemia. Ther Drug Monit 2006; 28:800-806.
9. Szumlanski C, Otternes D, Her C, Lee D, Brandriff B, Kelsell D. Thiopurine methyltransferase pharmacogenetics: human gene cloning and characterization of a common polymorphism. DNA Cell Biol 1996; 15:17-30.
10. Yates CR, Krynetski EY, Loennechen T, et al. Molecular diagnosis of thiopurine S-methyltransferase deficiency: genetic basis for azathioprine and mercaptopurine intolerance. Ann Intern Med 1997; 126(8):608-614.
11. Tai HL, Krynetski EY, Yates CR, et al. Thiopurine S-methyltransferase deficiency: two nucleotide transitions define the most prevalent mutant allele associated with loss of catalytic activity in Caucasians. Am J Hum Genet 1996; 58:694-702.
12. Otterness D, Szulmanski C, Lennard L, et al. Human thiopurine methyltransferase pharmacogenetics: Gene sequence polymorphisms. Clin Pharmacol Ther 1997; 62:60-73.
13. Hamdan-Khalil R, Allorge D, Lo-Guidice JM, et al. In vitro characterization of four novel non-functional variants of thethiopurine S-methyltransferase. Biochem Biophys Res Commun 2003; 309(4):1005-1010.
14. Schaeffeler E, Eichelbaum M, Reinisch W, Zanger UM, Schwab M. Three novel thiopurine S-methyltransferase allelic variants (TPMT 20, 21, 22) - association with decreased enzyme function. Hum Mutat 2006; 27(9):976.
15. Collie-Duguid ES, Pritchard SC, Powrie RH, et al. The frequency and distribution of thiopurine methyltransferase alleles in Caucasian and Asian populations. Pharmacogenetics 1999; 9(1):37-42.
16. Coulthard SA, Howell C, Robson J, Hall AG. The relationship between thiopurine methyltransferase activity and genotype in blasts from patients with acute leukemia. Blood 1998; 92(8):2856-2862.
17. Lennard L, Chew TS, Lilleyman JS. Human thiopurine methyltransferase activity varies with red blood cell age. Br J Clin Pharmacol 2001; 52(5):539-546.
18. McLeod HL, Krynetski EY, Willimas JA, Evans WE. Higher activity of polymorphic thiopurine S-methyltransferase in erythrocytes from neonates compared to adults. Pharmacogenetics 1995; 5:281-286.
19. Ma XL, Wu MY, Hu YM, Zu P, Li ZG. Relationships between thiopurine methyltransferase gene polymorphisms and its enzymatic activity. Zhonghua Zhong Liu Za Zhi 2006; 28(6):456-459.
20. Spire-Vayron de la Moureyre C, Debuysere H, Fazio F, et al. Characterization of a variable number tandem repeat region in the thiopurine S-methyltransferase gene promoter. Pharmacogenetics 1999; 9(2):189-198.
21. Spire-Vayron de la Moureyre C, Debuysere H, Sabbagh N, et al. Detection of known and new mutations in the thiopurine S-methyltransferase gene by single strand conformation analysis. Human Mut 1998; 12:178-185.
22. Yan L, Zhang S, Eiff B, et al. Thiopurine methyltransferase polymorphic tandem repeat: genotype-phenotype correlation analysis. Clin Pharmacol Ther 2000; 68(2):210-219.
23. Stary J. Moderni lecba detske leukemia. Vox Pediatrie 2003; 9:16-20.
24. Shean WP, Metzger DA, Higuchi R. Chelex 100 as medium for simple extraction of DNA for PCR-based typing from forensic material. Bio Techniques 1991; 10:506-513.
25. Indjova D, Atanasova S, Shipkova M, Armstrong VW, Oellerich M, Svinarov D. Phenotypic and genotypic analysis of thiopurine S-methyltransferase polymorphism in the Bulgarian population. Ther Drug Monit 2003; 25(5):631-636.
26. Milek M, Murn J, Jaksic Z, Lukac-Bajalo J, Jazbec J, Mlinaric-Rascan I. Thiopurine S-methyltransferase pharmacogenetics: genotype to phenotype correlation in the Slovenian population. Pharmacology 2006; 77(3):105-114.
27. Lysaa RA, Giverhaug T, Wold HL, Aarbakke J. Inhibition of human thiopurine methyltransferase by furosemide bendroflumethiazide and trichlormethiazide. Eur J Clin Pharmacol 1996; 49:393-396.
28. Pazmiûo PA, Sladek SL, Weinshilboum RM. Thiol S-methylation in uremia: erythrocyte enzyme activities and plasma inhibitors. Clin Pharmacol Ther 1980; 28:356-367.
29. McLeod HL, Relling MV, Liu Q, Pui CH, Evans WE. Polymorphic thiopurine methyltransferase in erythrocytes is indicative of activity in leukemic blasts from children with acute lymphoblastic leukemia. Blood 1995; 85(7):1897-1902.
30. Lilleyman JS, Lennard L. Mercaptopurine metabolism and risk of relapse in childhood lymphoblastic leukaemia. Lancet 1994; 343:1188-1190.
31. Lilleyman JS, Lennard L. Non-compliance with oral chemotherapy in childhood leukemia. An overlooked and costly cause of late relapse. BMJ 1996; 313:1219-1220.